Clinical Trials · NCT07152730
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
- Phase
- Phase 1
- Recruitment status
- Withdrawn
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 0
- Start date
- Sep 2025
- Locations
- 1 site, United States
- Primary endpoint
- Cmax: maximum observed plasma concentration from Part 1- Pulse 1